CIK 0001662774
- Non-accelerated filer
- Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 901024039
- Phone
- +1 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-28 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Option exercise · Stock Option (right to buy) | −20,000 | 215,594 | ||
| 2021-06-28 | McLoughlin Margaret Director | Sale | −200 | $55.01 | $11K | 350 |
| 2021-06-28 | McLoughlin Margaret Director | Sale | −250 | $55.03 | $14K | 100 |
| 2021-06-28 | McLoughlin Margaret Director | Sale | −100 | $55.73 | $6K | 0 |
| 2021-06-16 | Senner Christopher J. Director | Grant or award · Stock Option (right to buy) | +11,029 | 11,029 | ||
| 2021-06-16 | RYAN UNA S Director | Grant or award · Stock Option (right to buy) | +11,029 | 11,029 | ||
| 2021-06-16 | McLoughlin Margaret Director | Grant or award · Stock Option (right to buy) | +11,029 | 11,029 | ||
| 2021-06-16 | Lamond David Director | Grant or award · Stock Option (right to buy) | +11,029 | 11,029 | ||
| 2021-05-10 | Lynch Casey Chief Executive Officer | Sale | −13,584 | $33.75 | $458K | 995,190 |
| 2021-05-10 | Lynch Casey Chief Executive Officer | Sale | −9,918 | $34.89 | $346K | 985,272 |
| 2021-05-10 | Lynch Casey Chief Executive Officer | Sale | −6,315 | $35.81 | $226K | 978,957 |
| 2021-05-10 | Lynch Casey Chief Executive Officer | Sale | −183 | $36.73 | $7K | 978,774 |
| 2021-03-24 | Lamond David Director | Purchase | +50,000 | $33.77 | $1.7M | 1,847,109 |
| 2021-03-22 | Lynch Casey Chief Executive Officer | Sale | −11,211 | $35.10 | $394K | 1,027,563 |
| 2021-03-22 | Lynch Casey Chief Executive Officer | Sale | −18,089 | $35.85 | $648K | 1,009,474 |
| 2021-03-22 | Lynch Casey Chief Executive Officer | Sale | −300 | $36.58 | $11K | 1,009,174 |
| 2021-03-22 | Lynch Casey Chief Executive Officer | Sale | −400 | $36.60 | $15K | 1,008,774 |
| 2021-03-04 | Lamond David Director | Gift | +1,534,720 | 1,534,720 | ||
| 2021-03-04 | Lamond David Director | Purchase | +16,621 | $34.28 | $570K | 1,763,730 |
| 2021-03-04 | Lamond David Director | Purchase | +13,310 | $35.00 | $466K | 1,777,040 |
Page 11 of 18 · 350 trades